Christine A. Ciunci, MD MSCE

faculty photo
Assistant Professor of Clinical Medicine
Department: Medicine

Contact information
Abramson Cancer Center
Penn Presbyterian Medical Center
Cupp Building 1st Floor
51 N 39th Street
Philadelphia, PA 19104
Office: 215-662-9801
Education:
BS (Biology)
Ursinus College, 2004.
MD (Medicine)
Temple University, 2008.
MSCE (MSCE)
University of Pennsylvania School of Medicine, 2014.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

thoracic malignancies
lung cancer
head and neck cancer

Description of Research Expertise

thoracic malignancies
lung cancer
head and neck cancer

Selected Publications

Grewal Amardeep S, Min Eun Jeong, Long Qi, Grewal Sharonjit K, Jain Varsha, Levin William P, Cengel Keith A, Swisher-McClure Samuel, Aggarwal Charu, Bauml Joshua M, Singh Aditi, Ciunci Christine, Cohen Roger B, Langer Corey, Feigenberg Steven J, Berman Abigail T: Early Tumor and Nodal Response in Patients with Locally-advanced NSCLC Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy: Tumor Regression Predicts Outcomes in LA-NSCLC. International journal of radiation oncology, biology, physics Oct 2019.

Bauml Joshua M, Mick Rosemarie, Ciunci Christine, Aggarwal Charu, Davis Christiana, Evans Tracey, Deshpande Charuhas, Miller Linda, Patel Pooja, Alley Evan, Knepley Christina, Mutale Faith, Cohen Roger B, Langer Corey J: Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial. JAMA oncology Jul 2019.

Bauml Joshua M, Vinnakota Ravi, Anna Park Yeun-Hee, Bates Susan E, Fojo Tito, Aggarwal Charu, Limaye Sewanti, Damjanov Nevena, Di Stefano Jessica, Ciunci Christine, Genden Eric M, Wisnivesky Juan P, Ferrandino Rocco, Mamtani Ronac, Langer Corey J, Cohen Roger B, Sigel Keith: Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Journal of the National Cancer Institute 111(5): 490-497, May 2019.

Aggarwal Charu, Thompson Jeffrey C, Black Taylor A, Katz Sharyn I, Fan Ryan, Yee Stephanie S, Chien Austin L, Evans Tracey L, Bauml Joshua M, Alley Evan W, Ciunci Christine A, Berman Abigail T, Cohen Roger B, Lieberman David B, Majmundar Krishna S, Savitch Samantha L, Morrissette Jennifer J D, Hwang Wei-Ting, Elenitoba-Johnson Kojo S J, Langer Corey J, Carpenter Erica L: Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer. JAMA oncology 5(2): 173-180, Feb 2019.

Bange Erin, Marmarelis Melina E, Hwang Wei-Ting, Yang Yu-Xiao, Thompson Jeffrey C, Rosenbaum Jason, Bauml Joshua M, Ciunci Christine, Alley Evan W, Cohen Roger B, Langer Corey J, Carpenter Erica, Aggarwal Charu: Impact of and Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With -Mutated Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 3, 2019.

Aggarwal Charu, Davis Christiana W, Mick Rosemarie, Thompson Jeffrey C, Ahmed Saman, Jeffries Seth, Bagley Stephen, Gabriel Peter, Evans Tracey L, Bauml Joshua M, Ciunci Christine, Alley Evan, Morrissette Jennifer J D, Cohen Roger B, Carpenter Erica L, Langer Corey J: Influence of Mutation on Survival in Patients With Advanced -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 2018, 2018.

Evans Tracey, Ciunci Christine, Hertan Lauren, Gomez Daniel: Special topics in immunotherapy and radiation therapy: reirradiation and palliation. Translational lung cancer research 6(2): 119-130, Apr 2017.

Chao Hann-Hsiang, Berman Abigail T, Simone Charles B, Ciunci Christine, Gabriel Peter, Lin Haibo, Both Stefan, Langer Corey, Lelionis Kristi, Rengan Ramesh, Hahn Stephen M, Prabhu Kiran, Fagundes Marcio, Hartsell William, Mick Rosemarie, Plastaras John P: Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 12(2): 281-292, Feb 2017.

Bagley SJ, Kothari S, Aggarwal C, Bauml JB, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachania A, Langer CJ: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung Cancer 106: 1-7, 2017.

Bagley Stephen J, Kothari Shawn, Aggarwal Charu, Bauml Joshua M, Alley Evan W, Evans Tracey L, Kosteva John A, Ciunci Christine A, Gabriel Peter E, Thompson Jeffrey C, Stonehouse-Lee Susan, Sherry Victoria E, Gilbert Elizabeth, Eaby-Sandy Beth, Mutale Faith, DiLullo Gloria, Cohen Roger B, Vachani Anil, Langer Corey J: Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 106: 1-7, 04 2017.

back to top
Last updated: 11/10/2019
The Trustees of the University of Pennsylvania